🇺🇸 FDA
Pipeline program

Match placebo to test product, METHOTREXATE , SAR441566, SAR441566

DRI17821

Phase 2 small_molecule active

Quick answer

Match placebo to test product, METHOTREXATE , SAR441566, SAR441566 for Rheumatoid arthritis is a Phase 2 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pharma Bristol-Myers Squibb
Indication
Rheumatoid arthritis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials